TABLE 5.
Summary of LAMA2-CMD mice lacking other genes.
| Approach | Deletion | Mouse model | Muscle condition and overall health | References |
| Extracellular matrix and receptor modulation | Integrin α7 | dy3K/dy3K | No difference | Gawlik and Durbeej, 2015 |
| Dystrophin | dy3K/dy3K | Worsened | Gawlik et al., 2014 | |
| β-sarcoglycan | dy3K/dy3K | Worsened | Gawlik et al., 2014 | |
| Laminin α4 | dy3K/dy3K | Overall phenotype worsened but skeletal muscle condition remains to be reported | Miner et al., 2004 | |
| dy2J/dy2J | ||||
| Apoptosis inhibition | Bax | dyW/dyW | Improved | Girgenrath et al., 2004 |
| Modulation mitochondrial permeability transition | Cyclophilin D | dyW/dyW | Improved | Millay et al., 2008 |
| Inflammation and fibrosis modulation | Complement C3 | dy/dy | Improved | Connolly et al., 2002 |
| Galectin-3 | dy3K/dy3K | No difference | Gawlik et al., 2017 | |
| Osteopontin | dy3K/dy3K | Slightly worsened | Gawlik et al., 2017 | |
| miR-21 | dy3K/dy3K | No difference | Moreira Soares Oliveira et al., 2017 | |
| dy2J/dy2J | No difference | |||
| Muscle growth | Myostatin | dyW/dyW | No difference | Li et al., 2005 |